CYTOKINETICS INC — Director's Dealing 2025

Mar 17, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2025-03-17

Reporting Person: Callos Andrew (EVP, Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-03-17	Common Stock	M	20900	$23.26	Acquired	58563	Direct
2025-03-17	Common Stock	S	20900	$45.14	Disposed	37663	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-03-17	Non-Qualified Stock Option (Right to Buy)	$23.26	M	20900	Disposed	2031-03-31	Common Stock (20900)	Direct

Footnotes

F1: Stock options will vest over 4 years from the date of the grant, with 1/4th of the shares underlying the reporting person's option vesting on the one-year anniversary of the grant date and the remaining shares thereafter vesting monthly at a rate of 1/48th of the shares underlying the reporting person's option over the subsequent 36 months, subject to the reporting person's continued employment with the Issuer.